AI assistant
Sending…
Personalis, Inc. — Director's Dealing 2022
May 19, 2022
32721_dirs_2022-05-18_e95b88f8-47c0-4c75-93c6-2f874cf94288.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Personalis, Inc. (PSNL)
CIK: 0001527753
Period of Report: 2022-05-16
Reporting Person: Chen Richard (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-04-29 | Common Stock | A | 1558 | $4.76 | Acquired | 157116 | Direct |
| 2022-05-16 | Common Stock | S | 1286 | $4.86 | Disposed | 155830 | Direct |
Footnotes
F1: Includes 1,558 shares acquired under the Issuer's Employee Stock Purchase Plan dated April 29, 2022.
F2: Shares sold to cover tax obligation from settlement of vested restricted stock units.
F3: This reflects a reduction of 538 shares due to a scrivener's error on the reporting person's prior filing and does not indicate a purchase and/or sale of such shares.
More from Personalis, Inc.
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Regulatory Filings
2026
Mar 17
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26